Skip to main content
SpringerLink
Log in

Role of obesity on all-cause mortality in whites with type 2 diabetes from Italy

  • Original Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

Mortality rate of diabetic patients is twice as much that of non-diabetic individuals. The role of obesity on mortality risk in patients with type 2 diabetes is controversial. Aim of our study was to address the relationship between obesity and all-cause mortality in a real-life set of white patients with type 2 diabetes from central-southern Italy from the Gargano Mortality Study (GMS). In addition, we used genetic data from genome-wide association studies (GWAs)-derived single nucleotide polymorphisms (SNPs) firmly associated with body mass index (BMI), in order to investigate the intrinsic nature of reduced mortality rate we, in fact, observed in obese patients. Study subjects with type 2 diabetes (n = 764) are part of the GMS, which is aimed at unraveling predictors of incident all-cause mortality. Time-to-death analyses were performed by Cox regression. Association between genotype risk score and obesity was tested by logistic regression. Of the 32 SNPs firmly associated with BMI, we investigated those with BMI β value ≥0.10 kg/m2 and allele frequency ≥10 %. Genotyping was performed by KBioscience (http://www.lgcgenomics.com/). In GMS, obesity predicted a 45 % reduction in all-cause mortality. Individuals with high “obesity genetic load” (i.e., those carrying >9 risk alleles) were 60 % more likely to be obese as compared to individuals with low “obesity genetic load.” Most importantly, mortality rate was not different in individuals with high and low “obesity genetic load,” thus indicating no role of obesity genes on all-cause mortality and speaking against a cause–effect relationship underlying the association between obesity and reduced mortality rate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Emerging Risk Factors Collaboration, Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, Whincup PH, Mukamal KJ, Gillum RF, Holme I, Njølstad I, Fletcher A, Nilsson P, Lewington S, Collins R, Gudnason V, Thompson SG, Sattar N, Selvin E, Hu FB, Danesh J (2011) Emerging risk factors collaboration diabetes mellitus, fasting glucose, and risk of cause-specific deaths. N Engl J Med 364(9):829–841

    Article  PubMed  CAS  Google Scholar 

  2. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet MS, Park Y, Pocobelli G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A, Zeleniuch-Jacquotte A, Willett WC, Thun MJ (2010) Body-mass index and mortality among 1.46 million white adults. N Engl J Med 363(23):2211–2219

    Article  PubMed  CAS  Google Scholar 

  3. Zoppini G, Verlato G, Targher G, Bonora E, Trombetta M, Muggeo M (2008) Variability of body weight, pulse pressure and glycaemia strongly predict total mortality in elderly type 2 diabetic patients. The Verona Diabetes Study. Diabetes Metab Res Rev 24(8):624–628

    Article  PubMed  Google Scholar 

  4. Eeg-Olofsson K, Cederholm J, Nilsson PM, Zethelius B, Nunez L, Gudbjörnsdóttir S, Eliasson B (2009) Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients. Diabetologia 52(1):65–73

    Article  PubMed  CAS  Google Scholar 

  5. Perotto M, Panero F, Gruden G, Fornengo P, Lorenzati B, Barutta F, Ghezzo G, Amione C, Cavallo-Perin P, Bruno G (2011) Obesity is associated with lower mortality risk in elderly diabetic subjects: the Casale Monferrato study. Acta Diabetol. doi:10.1007/s00592-011-0338-1

  6. Carnethon MR, De Chavez PJ, Biggs ML, Lewis CE, Pankow JS, Bertoni AG, Golden SH, Liu K, Mukamal KJ, Campbell-Jenkins B, Dyer AR (2012) Association of weight status with mortality in adults with incident diabetes. JAMA 308(6):581–590

    Article  PubMed  CAS  Google Scholar 

  7. Kokkinos P, Myers J, Faselis C, Doumas M, Kheirbek R, Nylen E (2012) BMI-mortality paradox and fitness in African American and Caucasian men with type 2 diabetes. Diabetes Care 35(5):1017–1021

    Article  Google Scholar 

  8. Logue J, Walker JJ, Leese G, Lindsay R, McKnight J, Morris A, Philip S, Wild S, Sattar N, Group SDRNE (2013) Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality. Diabetes Care 36(4):887–893

    Article  PubMed  Google Scholar 

  9. WHO, Expert, Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363(9403):157–163

    Article  Google Scholar 

  10. De Cosmo S, Copetti M, Lamacchia O, Fontana A, Massa M, Morini E, Pacilli A, Fariello S, Palena A, Rauseo A, Viti R, Di Paola R, Menzaghi C, Cignarelli M, Pellegrini F, Trischitta V (2013) Development and validation of a predicting model of all-cause mortality in patients with type 2 diabetes mellitus. Diabetes Care. doi:10.2337/dc12-1906

  11. Speliotes EK, Willer CJ, Berndt SI (2010) Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 42:937–948

    Article  PubMed  CAS  Google Scholar 

  12. Day FR, Loos RJ (2011) Developments in obesity genetics in the era of genome-wide association studies. J Nutrigenet Nutrigenomics 4(4):222–238

    Article  PubMed  Google Scholar 

  13. Ishwaran H, Kogalur UB, Blackstone EH, Lauer MS (2008) Random survival forests. Ann App Statist 2:841–860

    Article  Google Scholar 

  14. Fleischmann E, Teal N, Dudley J, May W, Bower JD, Salahudeen AK (1999) Influence of excess weight on mortality and hospital stay in 1,346 hemodialysis patients. Kidney Int 55(4):1560–1567

    Article  PubMed  CAS  Google Scholar 

  15. Gómez-Díaz RA, Talavera JO, Pool EC, Ortiz-Navarrete FV, Solórzano-Santos F, Mondragón-González R, Valladares-Salgado A, Cruz M, Aguilar-Salinas CA, Wacher NH (2012) Metformin decreases plasma resistin concentrations in pediatric patients with impaired glucose tolerance: a placebo-controlled randomized clinical trial. Metabolism 61(9):1247–1255. doi:10.1016/j.metabol.2012.02.003

    Article  PubMed  Google Scholar 

  16. Shargorodsky M, Omelchenko E, Matas Z, Boaz M, Gavish D (2012) Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatisis: effects beyond glucose lowering? Cardiovasc Diabetol 11(61). doi:10.1186/1475-2840-11-61

  17. Guo Z, Zhang R, Li J, Xu G (2012) Effect of telmisartan on the expression of adiponectin receptors and nicotinamide adenine dinucleotide phosphate oxidase in the heart and aorta in type 2 diabetic rats. Cardiovasc Diabetol 11(94). doi:10.1186/1475-2840-11-94

  18. Fuke Y, Fujita T, Satomura A, Wada Y, Matsumoto K (2010) Alterations of insulin resistance and the serum adiponectin level in patients with type 2 diabetes mellitus under the usual antihypertensive dosage of telmisartan treatment. Diabetes Technol Ther 12(5):393–398

    Google Scholar 

  19. Wago T, Yoshimoto T, Akaza I, Tsuchiya K, Izumiyama H, Doi M, Hirata Y (2010) Improvement of endothelial function in patients with hypertension and type 2 diabetes after treatment with telmisartan. Hypertens Res 33(8):796–801

    Article  PubMed  CAS  Google Scholar 

  20. Koh KK, Quon MJ, Han SH, Chung WJ, Ahn JY, Seo YH, Kang MH, Ahn TH, Choi IS, Shin EK (2004) Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients. Circulation 110:3687–3692

    Article  PubMed  CAS  Google Scholar 

  21. Koh KK, Quon MJ, Han SH, Ahn JY, Jin DK, Kim HS, Kim DS, Shin EK (2005) Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes. Hypertension 45(6):1088–1093

    Google Scholar 

  22. Lazich I, Sarafidis P, de Guzman E, Patel A, Oliva R, Bakris G (2012) Effects of combining simvastatin with rosiglitazone on inflammation, oxidant stress and ambulatory blood pressure in patients with the metabolic syndrome: the SIROCO study. Diabetes Obes Metab 14(2):181–186

    Article  PubMed  CAS  Google Scholar 

  23. Didelez V, Sheehan N (2007) Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res 16:309–330

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This research was supported by Italian Ministry of Health Grants: RC2012 and RC2013 (R.D.P.), RC2012 and RC2013 (V.T.); Fondazione Roma “Sostegno alla ricerca scientifica biomedica 2008” (V.T.).

Author information

Authors and Affiliations

  1. Research Unit of Diabetes and Endocrine Diseases, Poliambulatorio Giovanni Paolo II, IRCCS “Casa Sollievo della Sofferenza”, Viale Padre Pio, 71013, San Giovanni Rotondo, Italy

    R. Di Paola, A. Marucci, C. Menzaghi, L. Salvemini & V. Trischitta

  2. Unit of Biostatistics, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy

    A. Fontana, M. Copetti & F. Pellegrini

  3. Unit of Endocrinology, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy

    S. De Cosmo

  4. Department of Experimental Medicine, “Sapienza” University, Rome, Italy

    V. Trischitta

Authors
  1. R. Di Paola
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Marucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Fontana
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Menzaghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. Salvemini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Copetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F. Pellegrini
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S. De Cosmo
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. V. Trischitta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to R. Di Paola or V. Trischitta.

Additional information

Communicated by Massimo Federici.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 27 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Di Paola, R., Marucci, A., Fontana, A. et al. Role of obesity on all-cause mortality in whites with type 2 diabetes from Italy. Acta Diabetol 50, 971–976 (2013). https://doi.org/10.1007/s00592-013-0509-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-013-0509-3

Keywords

Search

Navigation